Per ulteriori informazioni selezionare i riferimenti di interesse.
The potential of monoclonal antibodies to reduce reperfusion injury in myocardial infarction
BIODRUGS
Abciximab suppresses the rise in levels of circulating inflammatory markers after percutaneous coronary revascularization
CIRCULATION